🔎 Trials Near Me

Home › Atherosclerosis › Alabama

Atherosclerosis clinical trials in Alabama

8 studies for Atherosclerosis are looking for participants at sites in Alabama.

Cities in Alabama

Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)

  • Birmingham Clinical Research, Birmingham
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT07157774

A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis

  • Heart Center Research, LLC, Huntsville
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Sep 22, 2026 · NCT07521007

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

  • Heart Center Research, LLC, Huntsville
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07783802

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

  • Alliance For Multispecialty Research - Daphne, Daphne
  • Eastern Shore Research Institute, Fairhope
  • Heart Center Research LLC, Huntsville
  • and 2 more
RecruitingPhase 3
Ages 45 to 99 · All sexes · Updated Sep 22, 2026 · NCT07037433

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

  • Nephrology of North Alabama, Decatur
  • Nephrology Consultants, LLC, Huntsville
  • DaVita Clinical Research Montgomery, Montgomery
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT05485961

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

  • Research Site, Athens
  • Research Site, Birmingham
  • Research Site, Birmingham
  • and 8 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 24, 2026 · NCT07000357

Pelacarsen Roll-over Extension Program

  • Parkway Medical Center, Birmingham
RecruitingPhase 3
Ages 18 to 100 · All sexes · Updated Jul 29, 2026 · NCT06875973

Polygenic Risk Score Implementation and Stratification for Managing Blood Pressure

  • University of Alabama at Birmingham, Birmingham
Recruiting
Ages 18 to 55 · All sexes · Updated Sep 3, 2025 · NCT06962488

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.